$CYTH
Cyclo Therapeutics, Inc.

2023 Q1 Form 10-K Financial Statement

#000143774923007064 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $152.4K $186.8K $1.376M
YoY Change -21.8% -68.07% -13.24%
Cost Of Revenue $11.45K $16.61K $150.0K
YoY Change -44.93% -77.44% -10.1%
Gross Profit $141.0K $170.2K $1.226M
YoY Change -19.04% -66.73% -13.61%
Gross Profit Margin 92.49% 91.11% 89.1%
Selling, General & Admin $1.745M $1.963M $7.829M
YoY Change -13.6% 4.09% 19.73%
% of Gross Profit 1238.02% 1153.58% 638.65%
Research & Development $3.398M $3.185M $9.000M
YoY Change 213.47% 125.18% -1.68%
% of Gross Profit 2410.73% 1871.41% 734.17%
Depreciation & Amortization $4.819K $4.870K $19.48K
YoY Change 1.65% 15.68% 15.77%
% of Gross Profit 3.42% 2.86% 1.59%
Operating Expenses $3.398M $5.153M $9.000M
YoY Change 213.47% 55.93% -1.68%
Operating Profit -$5.007M -$4.983M -$15.62M
YoY Change 70.63% 78.39% 9.32%
Interest Expense $50.00 $2.480K $12.47K
YoY Change -98.85% 166.67% 265.69%
% of Operating Profit
Other Income/Expense, Net $47.00 $12.47K
YoY Change -99.97% 266.34%
Pretax Income -$5.007M -$4.980M -$15.45M
YoY Change 80.66% 78.36% 8.15%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.007M -$4.980M -$15.45M
YoY Change 80.66% 78.36% 8.15%
Net Earnings / Revenue -3285.25% -2666.18% -1123.08%
Basic Earnings Per Share -$0.46 -$1.83
Diluted Earnings Per Share -$0.46 -$0.59 -$1.83
COMMON SHARES
Basic Shares Outstanding 10.55M 8.482M 8.439M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $915.2K $1.543M $1.543M
YoY Change -92.24% -90.71% -90.71%
Cash & Equivalents $915.2K $1.543M $1.543M
Short-Term Investments
Other Short-Term Assets $2.703M $2.306M $2.306M
YoY Change -26.42% 12.08% 12.08%
Inventory $244.5K $254.5K $254.5K
Prepaid Expenses
Receivables $131.2K $54.99K $54.99K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.993M $4.159M $4.159M
YoY Change -74.81% -78.6% -78.6%
LONG-TERM ASSETS
Property, Plant & Equipment $50.37K $55.19K $56.66K
YoY Change -15.26% -7.38% -26.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $103.8K $56.66K $56.65K
YoY Change 40.35% -32.95% -32.95%
TOTAL ASSETS
Total Short-Term Assets $3.993M $4.159M $4.159M
Total Long-Term Assets $103.8K $56.66K $56.65K
Total Assets $4.097M $4.215M $4.215M
YoY Change -74.27% -78.41% -78.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.483M $3.481M $3.481M
YoY Change 56.65% -5.36% -5.36%
Accrued Expenses $16.97K $0.00 $0.00
YoY Change 16.55% -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $4.500M $3.481M $3.481M
YoY Change 56.44% -9.14% -9.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $36.53K
YoY Change
Total Long-Term Liabilities $36.53K $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.500M $3.481M $3.481M
Total Long-Term Liabilities $36.53K $0.00 $0.00
Total Liabilities $4.536M $3.481M $3.481M
YoY Change 57.71% -9.57% -9.57%
SHAREHOLDERS EQUITY
Retained Earnings -$68.81M -$63.80M
YoY Change 34.6% 31.96%
Common Stock $1.056K $849.00
YoY Change 25.42% 0.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$438.9K $734.5K $734.5K
YoY Change
Total Liabilities & Shareholders Equity $4.097M $4.215M $4.215M
YoY Change -74.27% -78.41% -78.41%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.007M -$4.980M -$15.45M
YoY Change 80.66% 78.36% 8.15%
Depreciation, Depletion And Amortization $4.819K $4.870K $19.48K
YoY Change 1.65% 15.68% 15.77%
Cash From Operating Activities -$4.370M -$2.747M -$15.11M
YoY Change -9.52% 5.17% 0.73%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $15.09K
YoY Change -100.0% -32.95%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $53.26K
YoY Change -100.0% -100.0% 42.71%
Cash From Investing Activities $0.00 $0.00 $38.17K
YoY Change -100.0% -100.0% 157.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.742M 0.000 $6.778K
YoY Change 55107.98% -100.0% -99.96%
NET CHANGE
Cash From Operating Activities -$4.370M -2.747M -$15.11M
Cash From Investing Activities $0.00 0.000 $38.17K
Cash From Financing Activities $3.742M 0.000 $6.778K
Net Change In Cash -$628.2K -2.747M -$15.07M
YoY Change -86.95% -133.61% -500.08%
FREE CASH FLOW
Cash From Operating Activities -$4.370M -$2.747M -$15.11M
Capital Expenditures $0.00 $0.00 $15.09K
Free Cash Flow -$4.370M -$2.747M -$15.13M
YoY Change -9.61% 5.17% 0.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8481848
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8481848
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8403869
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8403869
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52900 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
-0
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6370073
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2021Q4 us-gaap Assets
Assets
19520833 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
0-25466
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3029743
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6714 NW 16th Street, Suite B
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Gainesville
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32653
CY2022 dei City Area Code
CityAreaCode
386
CY2022 dei Local Phone Number
LocalPhoneNumber
418-8060
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
14693080 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10554900
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
East Brunswick, New Jersey
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1543418 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16612711 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54991 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
493113 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
254491 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
227437 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
45977 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
101135 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
42246 usd
CY2022Q4 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
2204520 usd
CY2021Q4 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
2014851 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4158555 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
19436335 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55188 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59583 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1470 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17636 usd
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
0 usd
CY2021Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
7279 usd
CY2022Q4 us-gaap Assets
Assets
4215213 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19245 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
133712 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3480669 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3677979 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3480669 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3830936 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
18034 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
849 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
841 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64533074 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64019513 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63799379 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48348491 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
734544 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15671863 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4215213 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19520833 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1375760 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1585756 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
3968681 usd
CY2021 us-gaap Salaries And Wages
SalariesAndWages
3838477 usd
CY2022 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
138929 usd
CY2021 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
156080 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8999543 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9153780 usd
CY2022 ctdh Repairs And Maintenance
RepairsAndMaintenance
11019 usd
CY2021 ctdh Repairs And Maintenance
RepairsAndMaintenance
10708 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
2417017 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
1474911 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1025635 usd
CY2021 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1061937 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
394009 usd
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
122833 usd
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
19481 usd
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
16827 usd
CY2022 ctdh Freight And Shipping
FreightAndShipping
13060 usd
CY2021 ctdh Freight And Shipping
FreightAndShipping
18336 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10272 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21927 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
16997646 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
15875816 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-15621886 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-14290060 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12474 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3405 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15450888 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14286655 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15450888 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14286655 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8439177
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6370073
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10452482 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
396306 usd
CY2021 ctdh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
7991101 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
295578 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10772751 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14286655 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15671863 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
15750 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
143763 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354056 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15450888 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
734544 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15450888 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14286655 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19481 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16827 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
158524 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10272 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21927 usd
CY2022 ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
15750 usd
CY2021 ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
124998 usd
CY2022 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
143763 usd
CY2021 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
50300 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
354056 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
295578 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-427850 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
444023 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27054 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10472 usd
CY2022 ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
189669 usd
CY2021 ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
1286899 usd
CY2022 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
58889 usd
CY2021 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-84228 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
297 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-200389 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
408246 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
336647 usd
CY2021 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-718643 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15114241 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15005298 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15086 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22500 usd
CY2022 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-53256 usd
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-37322 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38170 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14822 usd
CY2022 ctdh Net Proceeds From Sale Of Common Stock And Warrants And Exercise Of Warrants
NetProceedsFromSaleOfCommonStockAndWarrantsAndExerciseOfWarrants
0 usd
CY2021 ctdh Net Proceeds From Sale Of Common Stock And Warrants And Exercise Of Warrants
NetProceedsFromSaleOfCommonStockAndWarrantsAndExerciseOfWarrants
18763852 usd
CY2022 ctdh Proceeds From Issuance Repayments Of Longterm Debt
ProceedsFromIssuanceRepaymentsOfLongtermDebt
-8159 usd
CY2021 ctdh Proceeds From Issuance Repayments Of Longterm Debt
ProceedsFromIssuanceRepaymentsOfLongtermDebt
-6778 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6778 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18757074 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15069293 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3766598 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16612711 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12846113 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1543418 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16612711 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
3525 usd
CY2022 us-gaap Stock Issued1
StockIssued1
159513 usd
CY2021 us-gaap Stock Issued1
StockIssued1
446606 usd
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
71000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10300 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21800 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52900 usd
CY2021 us-gaap Depreciation
Depreciation
16827 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.17
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
150495
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.81
CY2022 us-gaap Use Of Estimates
UseOfEstimates
(q) USE OF ESTIMATES––The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company’s most significant estimate relates to inventory obsolescence and deferred tax valuation allowance. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15450888 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14286655 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63799379 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15114241 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1543418 usd
CY2022Q4 ctdh Working Capital Deficit
WorkingCapitalDeficit
677886 usd
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1375760 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1585756 usd
CY2021Q4 ctdh Deferred Tax Liabilities Stockbased Compensation
DeferredTaxLiabilitiesStockbasedCompensation
75000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
83000 usd
CY2016Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
10000 usd
CY2016Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
265000 usd
CY2016Q1 ctdh Mortgage Loans On Real Estate Monthly Payment
MortgageLoansOnRealEstateMonthlyPayment
3653 usd
CY2016Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0425 pure
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
156727 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
141641 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101539 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82058 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55188 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59583 usd
CY2022 us-gaap Depreciation
Depreciation
19481 usd
CY2022Q4 ctdh Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
66552 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
16166 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
17636 usd
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3662661
CY2021 ctdh Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
CY2021 ctdh Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
1599204
CY2021 ctdh Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
15271
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2048186
CY2022 ctdh Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
CY2022 ctdh Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
-0
CY2022 ctdh Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
2340
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2045846
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 ctdh Deferred Tax Asset Based Upon Expected Income Tax Rates
DeferredTaxAssetBasedUponExpectedIncomeTaxRates
23167000 usd
CY2022Q4 ctdh Valuation Allowance Percentage
ValuationAllowancePercentage
1 pure
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
42395000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
42395000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5464000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5500000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10761000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9570000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10354000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8104000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
19000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
13000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
45000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
105000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
99000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
245000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
0 usd
CY2022Q4 ctdh Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
1642000 usd
CY2021Q4 ctdh Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23167000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17703000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
83000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8000 usd
CY2022Q4 ctdh Deferred Tax Liabilities Stockbased Compensation
DeferredTaxLiabilitiesStockbasedCompensation
-0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.03 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.03 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.03 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.15 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.16 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.03 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.03 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.36 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.39 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
61168 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
49165 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
222700
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.45
CY2021 ctdh Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodGrantDateIntrinsicValue
3094 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
222700
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.45
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3094 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
226746
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.18
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23800
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.45
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
425646
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000914 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P8Y10M24D
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15450888 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14286655 usd
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8439177
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000

Files In Submission

Name View Source Status
ctdh-20221231_def.xml Edgar Link unprocessable
ctdh-20221231_cal.xml Edgar Link unprocessable
0001437749-23-007064-index-headers.html Edgar Link pending
0001437749-23-007064-index.html Edgar Link pending
0001437749-23-007064.txt Edgar Link pending
0001437749-23-007064-xbrl.zip Edgar Link pending
charta.jpg Edgar Link pending
chartb.jpg Edgar Link pending
cholesterolgraph01.jpg Edgar Link pending
ctdh-20221231.xsd Edgar Link pending
ctdh20221231_10k.htm Edgar Link pending
ex_487300.htm Edgar Link pending
ex_487301.htm Edgar Link pending
ex_487302.htm Edgar Link pending
ex_487303.htm Edgar Link pending
ex_487304.htm Edgar Link pending
ex_489654.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prinfs01.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
ctdh-20221231_lab.xml Edgar Link unprocessable
ctdh-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctdh20221231_10k_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending